Read + Share
Badar T, Atallah E, Shallis RM, Goldberg AD, et al. Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of
allogeneic stem cell transplantation on survival. Am J Hematol 2022;97:E232-E235.
PMID: 35338673
|
 |
|
Badar T, Atallah E, Shallis RM, Goldberg AD, et al. Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of
allogeneic stem cell transplantation on survival. Am J Hematol 2022;97:E232-E235.
PMID: 35338673
|
|
|
|